Darwin Management

Darwin Venture Management is a venture capital firm established in 2009 and headquartered in Taipei, Taiwan, with additional offices in Hsinchu and the United States. The firm focuses on investing in various sectors, including biotechnology, software, consumer goods, materials and equipment, semiconductors, communication, and surveillance, particularly targeting opportunities in Taiwan and Silicon Valley. Over the years, Darwin has managed eight funds, with a recent emphasis on Series A/B, late-stage, and secondary investments. In 2022, the firm expanded its portfolio by launching an evergreen angel fund to support promising early-stage teams, especially those emerging from Taiwan's distinguished academic and research institutions. The combination of cross-stage investment strategies and a technically proficient team distinguishes Darwin in the venture capital landscape.

Kazuaki Konno

Venture Partner

Kay Lin

Managing Partner

Jason Lu

Investment Director

Wei-Hsuan Tang

Principal

Steven Teng

Vice President

YJ Tsai

Partner

Yeou-Jyh Tsai Ph.D

Partner

Yao-Ting Wang

Co-Founding Partner

Emily Wu

Partner

Past deals in Series G

Leadgene Biomedical

Funding Round in 2023
Leadgene Biomedical is a biotechnology research company that specializes in the development and manufacture of in vitro diagnostic (IVD) raw materials, recombinant proteins, and antibodies. The company offers a range of products, including proteins, antibodies, and assay tools, and provides contracted research services to support various research and development needs. Through its innovative approaches, Leadgene Biomedical aims to advance the field of diagnostics and therapeutics.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.